Explore

Trendline Trendline
Innate Pharma Advances Immunotherapy Pipeline with Strategic Developments

Innate Pharma Advances Immunotherapy Pipeline with Strategic Developments

Innate Pharma Advances Immunotherapy Pipeline with Strategic Developments
Trendline Trendline
Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials

Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials

Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials
Trendline Trendline
Curis Reports Q1 2026 Financial Results and Advances Cancer Drug Trials

Curis Reports Q1 2026 Financial Results and Advances Cancer Drug Trials

Curis Reports Q1 2026 Financial Results and Advances Cancer Drug Trials
Trendline Trendline
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Advances

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Advances

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Advances
Trendline Trendline
Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026

Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026

Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026
Trendline Trendline
Palatin Technologies Reports Q3 2026 Financial Results and Business Update

Palatin Technologies Reports Q3 2026 Financial Results and Business Update

Palatin Technologies Reports Q3 2026 Financial Results and Business Update
Trendline Trendline
Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates

Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates

Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates
Trendline Trendline
Immunome Advances Oncology Pipeline with New Drug Application and Clinical Trials

Immunome Advances Oncology Pipeline with New Drug Application and Clinical Trials

Immunome Advances Oncology Pipeline with New Drug Application and Clinical Trials
Trendline Trendline
Incyte to Present Over 20 Abstracts at European Hematology Association 2026 Congress

Incyte to Present Over 20 Abstracts at European Hematology Association 2026 Congress

Incyte to Present Over 20 Abstracts at European Hematology Association 2026 Congress
Trendline Trendline
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments
Trendline Trendline
Anixa Biosciences Reports Positive Survival Data in Ovarian Cancer Trial

Anixa Biosciences Reports Positive Survival Data in Ovarian Cancer Trial

Anixa Biosciences Reports Positive Survival Data in Ovarian Cancer Trial
Trendline Trendline
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call